Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
mycophenolate mofetil
Amneal Pharma Australia Pty Ltd
Mycophenolate mofetil
Registered
Mycophenolate AN CMI v3.0 1 Mycophenolate AN Mycophenolate Mofetil 500 mg Tablets CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Mycophenolate AN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Mycophenolate AN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT MYCOPHENOLATE AN IS USED FOR Mycophenolate AN contains the active ingredient mycophenolate mofetil. Mycophenolate AN belongs to a group of medicines called immunosuppressants. Immunosuppressants are used to prevent rejection of transplanted organs, and work by stopping your immune system from reacting to the transplanted organ. There are many different types of medicines used to prevent transplant rejection. Mycophenolate AN belongs to a new group of these medicines. Mycophenolate AN may be used together with other medicines known as cyclosporin and corticosteroids. Your doctor, however, may have prescribed Mycophenolate AN for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY MYCOPHENOLATE AN HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor’s prescription. Mycophenolate AN is not addictive. BEFORE YOU TAKE MYCOPHENOLATE AN _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE MYCOPHENOLATE AN IF: 1. YOU HAVE HAD AN ALLERGIC REACTION TO MYCOPHENOLATE AN OR ANY INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of face, lips, tongue or other parts of the body • rash, itching, hives on the skin 2. YOU ARE PREGNANT. Mycophenolate AN is harmful to an unborn baby when taken by a pregnant woman. There have been cases of miscarriage and severe b Read the complete document
MYCOPHENOLATE AN (Mycophenolate mofetil 500 mg tablets) Mycophenolate AN PI v3.0 Page 1 of 33 PRODUCT INFORMATION MYCOPHENOLATE AN (MYCOPHENOLATE MOFETIL 500 MG TABLETS) NAME OF THE MEDICINE Mycophenolate mofetil CAS -128794-94-5 Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid. The chemical name for mycophenolate mofetil is 2-morpholinoethyl(_E_)-6-(1,3-dihydro-4- hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate. It has a molecular formula of C 23 H 31 NO 7 and a molecular weight of 433.50. DESCRIPTION Mycophenolate mofetil is a white to off-white crystalline powder. It is freely soluble in dimethyl sulfoxide, tetrahydrofuran, acetone, acetonitrile, dichloromethane, and ethyl acetate; soluble in methanol and propylene carbonate; sparingly soluble in anhydrous ethanol; slightly soluble in 2-propanol, diethyl ether, and very slightly soluble in hexane. It is practically insoluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic media (4.27 mg/mL at pH 3.6). Mycophenolate AN are available as purple-coloured film-coated tablets containing 500 mg of mycophenolate mofetil with the excipients microcrystalline cellulose, povidone, hydroxypropylcellulose, croscarmellose sodium, purified talc , magnesium stearate and opadry complete film coating system 03B50110 purple (PI number: 12853). PHARMACOLOGY MECHANISM OF ACTION Mycophenolic acid (MPA) is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH) which inhibits the _ de novo_ pathway of guanosine nucleotide synthesis without incorporation into DNA. Based on Chinese hamster MYCOPHENOLATE AN (Mycophenolate mofetil 500 mg tablets) Mycophenolate AN PI v3.0 Page 2 of 33 inosine-5’-monophosphate dehydrongenase (IMPDH) in complex with inosine-5’- monophosphate (IMP) and mycophenolic acid (MPA), the mechanism by which mycophenolic acid (MPA) inhibits the enzymatic activity of IMPDH (human type II) appears to be related to the ability of mycophenolic acid Read the complete document